Protease-activated receptor-1 impedes prostate and intestinal tumor progression in mice.

Protease-activated receptor-1 impedes prostate and intestinal tumor progression in mice.
复制标题

DOI:
10.1111/jth.14277
复制
发表时间:
2018-11
期刊:
Journal of thrombosis and haemostasis : JTH
影响因子:
--
通讯作者:
Palumbo JS
Palumbo JS
中科院分区:
其他
文献类型:
--
作者:
Adams GN;Sharma BK;Rosenfeldt L;Frederick M;Flick MJ;Witte DP;Mosnier LO;Harmel-Laws E;Steinbrecher KA;Palumbo JS

文献摘要

参考文献

被引文献

相似文献

Multiple studies have implicated Protease Activated Receptor-1 (PAR-1), a G-protein coupled receptor activated by proteolytic cleavage of its N-terminus, as one target coupling thrombin-mediated proteolysis to tumor progression. We analyzed the role of PAR-1 in the setting of two distinct spontaneously developing tumor models in mice. We interbred PAR-1-deficient mice with TRAMP (Transgenic Adenocarcinoma of the Mouse Prostate) mice, which spontaneously develop prostate tumors, and adenomatous polyposis coli Min (APCMin/+) mice, which spontaneously develop intestinal adenomas. Analyses of TRAMP mice with advanced disease (30 weeks) revealed that PAR-1 deficiency resulted in significantly larger and more aggressive prostate tumors. Prostates collected at an earlier time point (12 weeks of age) revealed that PAR-1 promotes apoptosis in transformed epithelia. In vitro analyses of TRAMP-derived cells revealed that activated protein C-mediated PAR-1 cleavage can induce tumor cell apoptosis, suggesting tumor cell intrinsic PAR-1 functions can limit tumor progression. Paralleling results in TRAMP mice, PAR-1-deficient APCMin/+ mice developed 3-fold more adenomas than PAR-1 expressing mice, and the adenomas that formed were significantly larger. Moreover, loss of PAR-1 expression was shown to limit apoptosis in transformed intestinal epithelial cells. Together, these results demonstrate a previously unrecognized role for PAR-1 in impeding tumor progression in vivo. These results also offer a cautionary note suggesting that long-term PAR-1 inhibition could increase malignancy risk in some contexts.
DOI: 10.1158/0008-5472.can-15-0964
发表时间: 2015-10-01
期刊: Cancer research
影响因子: 11.2
作者:
Adams GN;Rosenfeldt L;Frederick M;Miller W;Waltz D;Kombrinck K;McElhinney KE;Flick MJ;Monia BP;Revenko AS;Palumbo JS
通讯作者: Palumbo JS
DOI: 10.1074/jbc.m113.483123
发表时间: 2013-11-15
影响因子: 4.8
作者:
Mihara, Koichiro;Ramachandran, Rithwik;Hollenberg, Morley D.
通讯作者: Hollenberg, Morley D.
DOI: 10.1371/journal.pone.0111550
发表时间: 2014-11-03
期刊: PLOS ONE
影响因子: 3.7
作者:
Fazzini, Alessandra;D'Antongiovanni, Vanessa;Mazzoni, Maria Rosa
通讯作者: Mazzoni, Maria Rosa
DOI: 10.1002/pros.20326
发表时间: 2006-02-15
期刊: PROSTATE
影响因子: 2.8
作者:
Kaushal, V;Kohli, M;Mukunyadzi, P
通讯作者: Mukunyadzi, P
DOI: 10.1002/ijc.28726
发表时间: 2014-11-15
影响因子: 6.4
作者:
Queiroz, Karla C. S.;Shi, Kun;Spek, C. Arnold
通讯作者: Spek, C. Arnold